Literature DB >> 23516040

Sequence-specific apolipoprotein A-I effects on lecithin:cholesterol acyltransferase activity.

Alexander D Dergunov1.   

Abstract

Existing kinetic data of cholesteryl ester formation by lecithin:cholesterol acyltransferase in discoidal high-density lipoproteins with 34 mutations of apoA-I that involved all putative helices were grouped by cluster analysis into four noncoincident regions with mutations both without any functional impairment and with profound isolated (V- and K-mutations) or common (VK-mutations) effect on V(max)(app) and K(m)(app). Data were analyzed with a new kinetic model of LCAT activity at interface that exploits the efficiency of LCAT binding to the particle, particle dimensions, and surface concentrations of phosphatidylcholine and cholesterol. V-mutations with major location in the central part and C-domain affected the second-order rate constant of cholesteryl ester formation at the solvolysis of acyl-enzyme intermediate by cholesterol as nucleophile. The central region in apoA-I sequence is suggested to influence the proper positioning of cholesterol molecule toward LCAT active center with major contribution of arginine residue(s). K-mutations with major location in N-domain may affect binding and stability of enzyme-phosphatidylcholine complex. VK-mutations may possess mixed effects; the independent binding measurement may segregate individual steps.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23516040     DOI: 10.1007/s11010-013-1619-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  50 in total

Review 1.  Apolipoprotein A-I: structure-function relationships.

Authors:  P G Frank; Y L Marcel
Journal:  J Lipid Res       Date:  2000-06       Impact factor: 5.922

2.  Identification of a domain of lecithin-cholesterol acyltransferase that is involved in interfacial recognition.

Authors:  S Adimoolam; A Jonas
Journal:  Biochem Biophys Res Commun       Date:  1997-03-27       Impact factor: 3.575

3.  Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase.

Authors:  S Roosbeek; B Vanloo; N Duverger; H Caster; J Breyne; I De Beun; H Patel; J Vandekerckhove; C Shoulders; M Rosseneu; F Peelman
Journal:  J Lipid Res       Date:  2001-01       Impact factor: 5.922

4.  Activation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices.

Authors:  Mary G Sorci-Thomas; Shaila Bhat; Michael J Thomas
Journal:  Clin Lipidol       Date:  2009-02

5.  Regulation of the activity and fatty acid specificity of lecithin-cholesterol acyltransferase by sphingomyelin and its metabolites, ceramide and ceramide phosphate.

Authors:  Papasani V Subbaiah; Peter Horvath; Srinivasa B Achar
Journal:  Biochemistry       Date:  2006-04-18       Impact factor: 3.162

6.  Discoidal complexes of A and C apolipoproteins with lipids and their reactions with lecithin: cholesterol acyltransferase.

Authors:  A Jonas; S A Sweeny; P N Herbert
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

7.  Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.

Authors:  Angeliki Chroni; Horng-Yuan Kan; Adelina Shkodrani; Tong Liu; Vassilis I Zannis
Journal:  Biochemistry       Date:  2005-03-15       Impact factor: 3.162

8.  Influence of tertiary structure domain properties on the functionality of apolipoprotein A-I.

Authors:  Masafumi Tanaka; Mao Koyama; Padmaja Dhanasekaran; David Nguyen; Margaret Nickel; Sissel Lund-Katz; Hiroyuki Saito; Michael C Phillips
Journal:  Biochemistry       Date:  2008-01-19       Impact factor: 3.162

9.  Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.

Authors:  Georgios Koukos; Angeliki Chroni; Adelina Duka; Dimitris Kardassis; Vassilis I Zannis
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

10.  Novel N-terminal mutation of human apolipoprotein A-I reduces self-association and impairs LCAT activation.

Authors:  Paul M M Weers; Arti B Patel; Leon C-P Wan; Emmanuel Guigard; Cyril M Kay; Anouar Hafiane; Ruth McPherson; Yves L Marcel; Robert S Kiss
Journal:  J Lipid Res       Date:  2010-09-30       Impact factor: 5.922

View more
  1 in total

1.  Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.

Authors:  Anouar Hafiane; John K Bielicki; Jan O Johansson; Jacques Genest
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.